White House: US Not Dependent on Johnson & Johnson for Vaccination Goals
This comes after some problems at an independent manufacturing facility that makes the drug that goes into the Johnson & Johnson vaccine.
That plant, under the company Emergent BioSolutions, does not yet have FDA Authorization to send out its material.
That has led to delays in Johnson & Johnson vaccine deliveries.
Slavitt says that’s not a concern as far as overall supply and availability.
He added that there are enough doses to continue vaccinating Americans at 3 million per day, and then some.